Ecosystem perspectives are needed to manage zoonotic risks under climate change

Climate change and biodiversity loss are among this century’s greatest threats to human health and are exposing people worldwide to increasing food and water insecurity, extreme weather, pollution, and infectious disease threats.1 2 Zoonotic infectious diseases are situated at this nexus between environmental change, ecosystems, and health. Zoonotic pathogens and parasites are maintained in an animal reservoir and regularly or sporadically spill over to cause disease in humans,3 sometimes leading to sustained human-to-human or vectorborne epidemics (eg, severe acute respiratory syndrome coronaviruses (SARS-CoV), Ebola, plague) but more commonly to endemic or sporadic disease (eg, leptospirosis, helminthiases, Lyme disease, hantavirus diseases)

Streptococcus pyogenes infection in a free-living European hedgehog (Erinaceus europaeus)

Streptococcus pyogenes, a common pathogen of humans, was isolated from the carcass of a free-living European hedgehog (Erinaceus europaeus) found in northern England in June 2014. The animal had abscessation of the deep right cervical lymph node, mesenteric lymph nodes and liver. The S. pyogenes strain isolated from the lesions, peritoneal and pleural cavities was characterised as emm 28, which can be associated with invasive disease in humans. This is the first known report of S. pyogenes in a hedgehog and in any free-living wild animal that has been confirmed by gene sequencing. As close associations between wild hedgehogs and people in England are common, we hypothesise that this case might have resulted from anthroponotic infection

Emerging fungal pathogen Ophidiomyces ophiodiicola in wild European snakes

Snake fungal disease (SFD) is an emerging disease of conservation concern in eastern North America. $\textit{Ophidiomyces ophiodiicola}$, the causative agent of SFD, has been isolated from over 30 species of wild snakes from six families in North America. Whilst $\textit{O. ophiodiicola}$ has been isolated from captive snakes outside North America, the pathogen has not been reported from wild snakes elsewhere. We screened 33 carcasses and 303 moulted skins from wild snakes collected from 2010–2016 in Great Britain and the Czech Republic for the presence of macroscopic skin lesions and $\textit{O. ophiodiicola}$. The fungus was detected using real-time PCR in 26 (8.6%) specimens across the period of collection. Follow up culture and histopathologic analyses confirmed that both $\textit{O. ophiodiicola}$ and SFD occur in wild European snakes. Although skin lesions were mild in most cases, in some snakes they were severe and were considered likely to have contributed to mortality. Culture characterisations demonstrated that European isolates grew more slowly than those from the United States, and phylogenetic analyses indicated that isolates from European wild snakes reside in a clade distinct from the North American isolates examined. These genetic and phenotypic differences indicate that the European isolates represent novel strains of $\textit{O. ophiodiicola}$. Further work is required to understand the individual and population level impact of this pathogen in Europe.This work was undertaken as part of the Garden Wildlife Health project www.gardenwildlifehealth.org. Funding was provided by the UK Department for the Environment Food & Rural Affairs and Welsh Government through the Animal Plant & Health Agency’s Diseases of Wildlife Scheme Scanning Surveillance Programme (Project ED1600), the Esmée Fairbairn Foundation, the Universities Federation for Animal Welfare, and the U.S. Geological Survey

Salmonella Enteritidis ST183: emerging and endemic biotypes affecting western European hedgehogs (Erinaceus europaeus) and people in Great Britain

The impacts of hedgehog (Erinaceus europaeus) Salmonella infection on public health and on animal welfare and conservation are unknown. We isolated Salmonella Enteritidis multi-locus sequence-type (ST)183 from 46/170 (27%) hedgehog carcasses (27 S. Enteritidis phage type (PT)11, 18 of a novel PT66 biotype and one with co-infection of these PTs) and from 6/208 (3%) hedgehog faecal samples (4 PT11, 2 PT66) from across Great Britain, 2012–2015. Whole genome phylogenetic analysis of the hedgehog isolates and ST183 from people in England and Wales found that PT11 and PT66 form two divergent clades. Hedgehog and human isolates were interspersed throughout the phylogeny indicating that infections in both species originate from a common population. PT11 was recovered from hedgehogs across England and Scotland, consistent with endemic infection. PT66 was isolated from Scotland only, possibly indicating a recent emergence event. People infected with ST183 were four times more likely to be aged 0–4 years than people infected by the more common ST11 S. Enteritidis. Evidence for human ST183 infection being non-foodborne included stronger correlation between geographic and genetic distance, and significantly increased likelihood of infection in rural areas, than for ST11. These results are consistent with hedgehogs acting as a source of zoonotic infection

The management of an oral anaplastic sarcoma in a pygmy hippopotamus (choeropsis liberiensis) using intralesional chemotherapy

An adult female captive pygmy hippopotamus (Choeropsis liberiensis) was diagnosed with an oral anaplastic sarcoma. The tumor was surgically debulked and intralesional chemotherapy with mitomycin C (0.4 mg/cm3 of tumor) and cisplatin (1 mg/cm3 of tumor) was administered. Chemotherapeutic treatment proved difficult due to the risks of repeated anesthetics and unknown drug efficacies. Marked proliferation of the mass was observed during estrus, and chemotherapy was repeated as an experimental treatment to slow tumor progression in order for the animal to remain in the species breeding program. Tumor proliferation was detected during the first trimester of pregnancy; however, in the lactation period, the mass became quiescent. No adverse reactions to chemotherapeutic drugs were observed and the animal continues to be monitored for tumor progression. This is the first report of an anaplastic sarcoma and of chemotherapy use in a pygmy hippopotamus and it highlights logistical considerations for treating neoplasia in this species